Followers | 43 |
Posts | 15914 |
Boards Moderated | 0 |
Alias Born | 09/16/2012 |
Saturday, November 04, 2023 9:02:53 PM
https://medtour.help/procedure/cancer-treatment-with-dendritic-cell-vaccine-cancerax/#:~:text=For%20comparison%2C%20treatment%20with%20dendritic,at%20a%20much%20lower%20cost.
https://veritalife.com/treatment/immune/dendritic-cell-therapy/
https://veritalife.com/treatment/immune/dendritic-cell-therapy/
https://bookinghealth.com/blog/diagnoses-and-treatment/diagnosis-and-treatment/298855-cancer-treatment-with-dendritic-cells.html?roistat=google6_g_146128176428_603263505790_dendritic%20cell%20therapy&roistat_referrer=&roistat_pos=&gclid=EAIaIQobChMIubKI-tKrggMVUFByCh1gyw3CEAAYAyAAEgKzjvD_BwE
https://iaso-cancer.com/en/dendritic-cell-therapy-dct/
https://www.immunitytherapycenter.com/therapies/dendritic-cell-vaccine/?utm_medium=adwords&utm_campaign=GS_NB_DSA&utm_source=%7BPPC%7D&utm_content=651387040509&utm_term=&gbraid=0AAAAADkG_BXJo3AxzWxo5sXLhlJM4txkH&gclid=EAIaIQobChMIve_axNOrggMVIkRyCh07wQNLEAAYAyAAEgI8VfD_BwE
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM